Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3157]

Cemiplimab monotherapy could be a new treatment option for first line advanced...

Dr Ana Baramidze - Todua Clinic, Tbilisi, Georgia

Cemiplimab monotherapy could be a new treatment option for first line advanced NSCLC patients ( Dr Ana Baramidze - Todua Clinic, Tbilisi, Georgia )

Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS...

Prof Salomon Manier - Hospital Center University De Lille, Lille, France

Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients ( Prof Salomon Manier - Hospital Center University De Lille, Lille, France )

Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies

Prof Philippe Moreau - University Hospital of Nantes, Nantes, France

Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC

Dr Marina Garassino - University of Chicago, Chicago, USA

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC ( Dr Marina Garassino - University of Chicago, Chicago, USA )

Common Sense Oncology in head & neck cancers

Dr Anil D'Cruz - Apollo Hospitals, Mumbai, India

Common Sense Oncology in head & neck cancers ( Dr Anil D'Cruz - Apollo Hospitals, Mumbai, India )

CAR-T - Choosing Wisely

Dr Gourav Gupta - Balco Medical Center, Raipur, India

CAR-T - Choosing Wisely ( Dr Gourav Gupta - Balco Medical Center, Raipur, India )

Reducing drug expenditures without harming patients

Dr Daniel A Goldstein - University of North Carolina, USA

Reducing drug expenditures without harming patients ( Dr Daniel A Goldstein - University of North Carolina, USA )

Surveillance imaging after curative-intent treatment for cancer- benefits...

Dr Christopher Booth - Queen's University, Kingston, Canada

Surveillance imaging after curative-intent treatment for cancer- benefits, harms and evidence ( Dr Christopher Booth - Queen's University, Kingston, Canada )

McVie-Veronesi Award Lecture “The quest to deliver a balance between the best...

Dr Anita Borges - S L Raheja Hospital, Mumbai, India

McVie-Veronesi Award Lecture “The quest to deliver a balance between the best care and Choosing Wisely” ( Dr Anita Borges - S L Raheja Hospital, Mumbai, India )

Weaving in Choosing Wisely, Common Sense Oncology in all aspects of global...

Dr Christopher Booth - Queen's University, Kingston, Canada

Weaving in Choosing Wisely, Common Sense Oncology in all aspects of global health ( Dr Christopher Booth - Queen's University, Kingston, Canada )

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate...

Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou )

ESMO 2024: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2024: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

More from ecancer